| 8.04 Data as of May 17 |  +0.04 / +0.50%Today’s Change | 1.50 Today|||52-Week Range 9.98 | +206.87% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Oliviero James F Iii Chief Financial Officer |  Sale | 5/13/2013 | 29,363 | $8.34 | $244.9K | -8.11% |
Bentsur Ronald Chief Executive Officer | Sale | 3/27/2013 | 31,231 | $6.88 | $214.9K | +17.03% |
Oliviero James F Iii Chief Financial Officer | Sale | 1/04/2013 | 10,859 | $2.74 | $29.8K | +194.51% |
Bentsur Ronald Chief Executive Officer | Sale | 1/04/2013 | 6,010 | $2.74 | $16.5K | +194.51% |
Oliviero James F Iii Chief Financial Officer | Sale | 10/03/2012 | 4,973 | $2.72 | $13.5K | +200.00% |
Bentsur Ronald Chief Executive Officer | Sale | 4/05/2013 | 1,795 | $6.93 | $12.4K | +9.99% |
Oliviero James F Iii Chief Financial Officer | Sale | 4/05/2013 | 1,484 | $6.93 | $10.3K | +9.99% |
Oliviero James F Iii Chief Financial Officer | Sale | 7/03/2012 | 4,559 | $1.99 | $9.1K | +302.00% |
Kaye Jack L /keryx Biopharma/ Director |  Gift | 6/27/2012 | 5,000 | $1.81 | $9.1K | +349.16% |
Kaye Jack L /keryx Biopharma/ Director | Gift | 6/27/2012 | 5,000 | $1.81 | $9.1K | +349.16% |
.
